共 50 条
- [41] p300 in prostate cancer proliferation and progressionCANCER RESEARCH, 2003, 63 (22) : 7638 - 7640Debes, JDSebo, TJLohse, CMMurphy, LMHaugen, DLTindall, DJ
- [42] Targeting CDCP1 gene transcription coactivated by BRD4 and CBP/p300 in castration-resistant prostate cancerOncogene, 2022, 41 : 3251 - 3262Donglei JiGuanglei ShangEnwei WeiYanjie JiaChunyu WangQiang ZhangLei Zeng
- [44] Targeting CDCP1 gene transcription coactivated by BRD4 and CBP/p300 in castration-resistant prostate cancerONCOGENE, 2022, 41 (23) : 3251 - 3262Ji, DongleiShang, GuangleiWei, EnweiJia, YanjieWang, ChunyuZhang, QiangZeng, Lei
- [45] Transcriptional/epigenetic regulator CBP/p300 in tumorigenesis: structural and functional versatility in target recognitionCELLULAR AND MOLECULAR LIFE SCIENCES, 2013, 70 (21) : 3989 - 4008Wang, FengMarshall, Christopher B.Ikura, Mitsuhiko
- [46] Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibitionMOLECULAR CELL, 2021, 81 (10) : 2183 - +Hogg, Simon J.Motorna, OlgaCluse, Leonie A.Johanson, Timothy M.Coughlan, Hannah D.Raviram, RamyaMyers, Robert M.Costacurta, MatteoTodorovski, IzabelaPijpers, LizzyBjelosevic, StefanWilliams, TobiasHuskins, Shannon N.Kearney, Conor J.Devlin, Jennifer R.Fan, ZhengJabbari, Jafar S.Martin, Ben P.Fareh, MohamedKelly, Madison J.Dupere-Richer, DaphneSandow, Jarrod J.Feran, BreonKnight, DeborahKhong, TiffanySpencer, AndrewHarrison, Simon J.Gregory, GarethWickramasinghe, Vihandha O.Webb, Andrew, ITaberlay, Phillippa C.Bromberg, Kenneth D.Lai, AlbertPapenfuss, Anthony T.Smyth, Gordon K.Allan, Rhys S.Licht, Jonathan D.Landau, Dan A.Abdel-Wahab, OmarShortt, JakeVervoort, Stephin J.Johnstone, Ricky W.
- [47] Beyond the BET Family: Targeting CBP/p300 with 4-Acyl PyrrolesANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2017, 56 (41) : 12476 - 12480Huegle, MartinLucas, XavierOstrovskyi, DmytroRegenass, PierreGerhardt, StefanEinsle, OliverHau, MirjamJung, ManfredBreit, BernhardGuenther, StefanWohlwend, Daniel
- [48] Discovery of CBPD-409 as a Highly Potent, Selective, and Orally Efficacious CBP/p300 PROTAC Degrader for the Treatment of Advanced Prostate CancerJOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (07) : 5351 - 5372Chen, ZhixiangWang, MiWu, DiminZhao, LijieMetwally, HodaJiang, WeiWang, YuBai, LongchuanMceachern, DonnaLuo, JieWang, MeilinLi, QiuxiaMatvekas, AleksasWen, BoSun, DuxinChinnaiyan, Arul M.Wang, Shaomeng
- [49] Therapeutic targeting of p300/CBP HAT domain for the treatment of NUT midline carcinomaOncogene, 2020, 39 : 4770 - 4779Xin ZhangTim ZegarAnais LucasChevaun Morrison-SmithTatiana KnoxChristopher A. FrenchStefan KnappSusanne MüllerJens T. Siveke
- [50] Therapeutic targeting of p300/CBP HAT domain for the treatment of NUT midline carcinomaONCOGENE, 2020, 39 (24) : 4770 - 4779Zhang, XinZegar, TimLucas, AnaisMorrison-Smith, ChevaunKnox, TatianaFrench, Christopher A.Knapp, StefanMuller, SusanneSiveke, Jens T.